Health Technology Assessment

Health Technology Assessment

Our fully integrated HTA teams are experts in developing and critiquing evidence submissions for health technology agencies around the globe

We provide end-to-end strategic consultancy and reimbursement support, navigating our clients through the complex policies and processes in their target markets

Our experts support all stages of the HTA submission process, from the early scoping phases through to handling the response to HTA body clarification questions

Broad experience with submission to HTA bodies across Europe, Canada and the US

Extensive experience with
England (NICE and NHS England), Scotland (SMC), Wales (AWMSG) & Ireland (NCPE) – 93% success rate

A cross-functional team of
HTA consultants, systematic review specialists, medical writers and health economists

Wide disease area experience
with extensive experience in oncology and infectious disease

Experts in
HTA landscape assessments and HTA feasibility assessments

Technical and strategic guidance
at each stage of the HTA process to maximise chance of success

Team members with previous experience working for UK HTA bodies and conducting critical appraisals of HTA submissions

Health Technology

End-to-end strategic consultancy

Stakeholder and early engagement

Evidence gap assessment

Patient-level data analysis

Strategy workshops

Literature review

Economic modelling

Dossier development and submission

Post-submission support

National and local adaptations

Advisory boards and expert validation

Expert opinion elicitation

Early access to medicines schemes

Contact HEOR

We would love to hear from you